Lewy body dementiaResearch
A recent study explores cerebrospinal fluid biomarkers including amyloid, p-tau, neurofilament light, and α-synuclein across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease. This research enhances understanding of biomarker profiles in these neurodegenerative conditions.
amyloid p tau neurofilament light and synuclein cerebrospinal fluid biomarkers across alzheimer s disease dementia with lewy bodies and parkinson s disease
Original title: “Amyloid, p-tau, neurofilament light, and α-synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease.”